Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2009 Third Quarter Earnings...

Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2009 Third Quarter
Earnings Conference Call on Friday, May 15, 2009 at 11:00 a.m. EDT

CHENGDU, China, May 11 /PRNewswire-Asia-FirstCall/ -- Tianyin
Pharmaceutical, Co., Inc., (NYSE Amex: TPI), a manufacturer and supplier of
modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today
announced that management will hold a conference call to discuss its 2009
fiscal third quarter at 11:00 a.m. EDT on Friday, May 15, 2009. Financial
results will be released on May 14, 2009 after the market closes.
Interested parties may access the call by dialing +1-877-941-2927 from
within the United States, or +1-480-629-9725 if calling internationally. The
conference ID is 4076664. It is advisable to dial in approximately 5-10
minutes prior to the start of the call. A replay will be available through May
29, 2009 and can be accessed by dialing +1-800-406-7325 (U.S.),
+1-303-590-3030 (Int'l), passcode 4076664.
This call is being web cast by ViaVid Broadcasting and can be accessed at
ViaVid's website at http://www.viavid.net or at the following link:
http://viavid.net/dce.aspx?sid=00006448 . To access the web cast, you will
need to have the Windows Media Player on your desktop. For the free download
of the Media Player please visit:
http://www.microsoft.com/windows/windowsmedia/en/download/default.asp .
About Tianyin Pharmaceuticals
Tianyin is a manufacturer and supplier of modernized Traditional Chinese
Medicine ("TCM") in China. It was established in 1994 and acquired by the
current management team in August 2003. It has a comprehensive product
portfolio of 39 products, 22 of which are listed in the highly selective
National Medicine Catalog of the National Medical Insurance program. Tianyin
owns and operates two GMP manufacturing facilities and an R&D platform
supported by leading Chinese academic institutions. The Company has a pipeline
of 40 pharmaceutical products pending approval. Tianyin has an extensive
nationwide distribution network throughout China with a sales force of 720
salespeople. Tianyin is headquartered in Chengdu, Sichuan Province with two
manufacturing facilities and a total of 1,365 employees. Tianyin achieved
revenue of approximately $33.5 million and net income of approximately $6
million in FY2008 ending June 30, 2008. For more information about Tianyin,
please visit http://www.tianyinpharma.com .
Safe Harbor Statement
The Statements which are not historical facts contained in this press
release are forward-looking statements that involve certain risks and
uncertainties including but not limited to risks associated with the
uncertainty of future financial results, additional financing requirements,
development of new products, government approval processes, the impact of
competitive products or pricing, technological changes, the effect of economic
conditions and other uncertainties detailed in the Company's filings with the
Securities and Exchange Commission.
For more information, please contact:

For the Company:
Allen Tang, Ph.D., MBA, Assistant to the CEO
Tel: +86-158-2122-5642
Email: Allen.y.tang@gmail.com

Investors:
Mr. Matthew Hayden, HC International
Tel: +1-561-245-5155
Email: matt.hayden@hcinternational.net
Web: http://www.hcinternational.net

SOURCE Tianyin Pharmaceutical, Co., Inc.

For the Company: Allen Tang, Ph.D., MBA, Assistant to the CEO,
+86-158-2122-5642, or Allen.y.tang@gmail.com; Investors: Mr. Matthew Hayden,
HC International, +1-561-245-5155, or matt.hayden@hcinternational.net